// App-Quantinova.ai

: Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Researchers

Presenter

  • Christi Ann Hayes

Principal Investigators

  • Kenneth R. Meehan

  • Elizabeth A O'Donnell

  • Aricca Van Citters

  • Kate L. Caldon

  • Charlotte M Coughenour

  • Dorothy R. McKenna

  • Carla Tarzia

  • Wenyan Zhao

  • Kimberley R Holt

  • Christopher H. Lowrey

  • John M. Hill

  • Tiffany D'Cruze

  • Megan M Holthoff

  • Tor Tosteson

  • Anna Tosteson

Medical Centers

  • Section of Hematology/Oncology, Dartmouth Hitchcock Medical Center, Lebanon, NH

  • Geisel School of Medicine at Dartmouth, Lebanon, NH

  • The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH

  • Dartmouth-Hitchcock Medical Center, Lebanon, NH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A